Afya Limited
NASDAQAFYA enters its August 26 Q2 print carrying the weight of a year-long analyst downgrade cycle — and a valuation that has cheapened enough to attract renewed attention. The analyst story is the defining tension here. Every major firm covering AFYA has moved in the same direction over the past eight months: down. JP Morgan cut from Overweight to Neutral in January, BofA downgraded…
AFYA short interest jumps 20.6% in one week to 0.92% of float, driven by rising bearish positioning as cost to borrow falls to 0.46%.
Snapshot as of 20 Sept 2026
AFYA enters its August 26 Q2 print carrying the weight of a year-long analyst downgrade cycle — and a valuation that has cheapened enough to attract renewed attention. The analyst story is the defining tension here.…
AFYA hits its Q1 earnings release today having already covered the analyst-downgrade story — the question now is whether the print itself shifts the narrative. Options positioning is notably relaxed heading into the…
AFYA reports Q1 results on June 22 with analysts having spent the past six months steadily marking down their views on the Brazilian medical education operator — a setup that now sits in tension with cheap-looking…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AFYA — free to start on ORTEX.
Sign up for free →Open AFYA on ORTEX